Drug development company Quotient Sciences has unveiled plans for a significant expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, PA. The $15 million investment will create a center of excellence for early-phase formulation development and clinical trial manufacturing.   The Garnet Valley site will focus on developing small molecule oral drug products, supporting development programs from the...